BioXcel Therapeutics, Inc.: Clinical stage company utilizing AI technology platform to identify improved therapies in neuroscience and immuno-oncology. BXCL501 (sublingual dexmedetomidine): Met primary, key secondary and exploratory endpoints in two pivotal Phase 3 trials for the acute treatment of agitation in patients with schizophrenia (SERENITY I) and bipolar disorder (SERENITY II). NDA submission to FDA planned 1Q21; Phase 1b/2 trial (TRANQUILITY) ongoing for the acute treatment of agitation associated with geriatric dementia. Data expected 4Q20; BXCL701 (innate immunity activator): Phase 1b/2 ongoing of BXCL701 and KEYTRUDA for Prostate Cancer (tNEPC).
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase III, Phase l or ll
Disease Space
Central Nervous System, Oncology
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology, Small Molecule
Website:
Address:
555 Long Wharf Drive
5th Floor
New Haven, Connecticut 06511
United States

Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13

  • Vimal Mehta, Dr, CEO

Top 10 Holders of BioXcel Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
State Street Corp. 5.40 974,381 45.33 13F 6/30/20
DNCA Finance SA 3.99 892,453 41.52 Stakes 3/3/20
Artemis Investment Management LLP 3.89 701,498 32.63 13F 6/30/20
The Vanguard Group, Inc. 3.72 674,432 31.37 Funds 9/30/20
Vanguard Group, Inc. (Subfiler) 3.01 543,381 25.28 13F 6/30/20
AllianceBernstein LP 2.80 504,405 23.46 13F 6/30/20
Avidity Partners Management LP 2.15 388,095 18.05 13F 6/30/20
BlackRock Fund Advisors 2.02 364,425 16.95 13F 6/30/20
Acuta Capital Partners LLC 1.89 340,500 15.84 13F 6/30/20
Citadel LP 1.74 313,962 14.61 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.